Edges in Network
| Network | GSE12093_top8000 - GSE12093 - SiGN-BN NNSR |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | ANXA1 |
| Upstream (Parents) |
|---|
| (<<) COL15A1 → ANXA1 |
| (<<) CFH → ANXA1 |
| (<<) C1S → ANXA1 |
| (<<) CAV1 → ANXA1 |
| Downstream (Children) |
|---|
| ANXA1 → COL15A1 (>>) |
| ANXA1 → CYP2B7P1///CYP2B6 (>>) |
| ANXA1 → CYP2B7P1 (>>) |
| ANXA1 → RARRES1 (>>) |
| ANXA1 → MET (>>) |
| ANXA1 → PLA2G2A (>>) |
| ANXA1 → CFHR1///CFH (>>) |
| ANXA1 → CFH (>>) |
| ANXA1 → MDFIC (>>) |
| ANXA1 → ALDH1A3 (>>) |
| ANXA1 → CYP2B6 (>>) |
| ANXA1 → SLC5A7 (>>) |
| ANXA1 → CHN1 (>>) |
| ANXA1 → TRBV10-2 (>>) |
| ANXA1 → WNT3 (>>) |
| ANXA1 → ZNHIT2 (>>) |
| ANXA1 → OPRL1 (>>) |
| ANXA1 → RBMS1 (>>) |
| ANXA1 → MMD (>>) |
